Arbutus Biopharma (ABUS) Earnings
|
Expand Research on ABUS
| Next EPS Date | 5/2/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -81.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/24  |
Q124 | N/A | -$0.10 | N/A | N/A | $4.51M | N/A | N/A | N/A | ||
| 2/29/24 |
Q423 | N/A | -$0.12 | N/A | N/A | $4.78M | N/A | N/A | N/A | ||
| 11/7/23 | Q323 | -$0.12 | -$0.11 | -$0.01 | $4.66M | $4.75M | N/A |  | | Details | |
| 8/3/23 | Q223 | -$0.10 | -$0.11 | +$0.01 | $4.65M | $6.18M | N/A | | | Details | |
| 5/4/23 |
Q123 | N/A | -$0.14 | N/A | N/A | $5.5M | N/A | N/A | N/A | ||
| 3/2/23 | Q422 | -$0.46 | -$0.13 | -$0.33 | $39M | $6.18M | N/A | | | Details | |
| 11/9/22 | Q322 | -$0.12 | -$0.14 | +$0.02 | $5.95M | $6.64M | N/A | | | Details | |
| 11/9/22 | Q322 | -$0.24 | -$0.14 | -$0.10 | $3.34M | $6.64M | N/A | | | Details |
